Transfusion medicine: An overview and update

Clinical Chemistry

Volumn 46, Issue 8 II, 2000, Pages 1270-1276

  Ness, P M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL BLOOD; DESMOPRESSIN; ERYTHROPOIETIN; HEMOPOIETIC GROWTH FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIUM CONTAMINATION; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL CHEMISTRY; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN; IMMUNOPATHOLOGY; RISK ASSESSMENT; SAFETY; UNITED STATES; VIRUS INACTIVATION;

BACTERIA (MICROORGANISMS);

EID: 0033897403     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1270     Document Type: Conference Paper

References (49)

1. Trends in the collection and transfusion of blood in the United States, 1987-1997
2. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: Report on the end of phase I trials
3. Two unit RBC apheresis and its potential advantages over traditional whole blood donation: A review
4. Red cell compatibility testing: A perspective for the future
5. Centralized transfusion services: A novel approach to the delivery of transfusion services
6. Acquired immunodeficiency syndrome (AIDS) associated with transfusions
7. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
8. Transmission of human immunodeficiency virus (HIV) by blood transfusion screened as negative for HIV antibody
9. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion: Evidence of volunteer blood donor cooperation
10. Human immunodeficiency virus type 2 infection in the United States: Epidemiology, diagnosis, and public health implications
11. Prevalence of immunodeficiency virus type 1 p24 antigen in US blood donors - An assessment of the efficacy of testing in donor screening
12. Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives
13. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery
14. Evaluation of screen blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells
15. The risk of transfusion-transmitted viral infections
16. A prospective study indicating that double-antibody radioimmunoassay reduces the incidence of post-transfusion hepatitis B
17. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-transmitted Viruses Study
18. Non-A, non-B hepatitis: Evolving epidemiologic and clinical perspective
19. The declining risk of post transfusion hepatitis C virus infection
20. An assay for circulating antibodies to a major etiologic virus of non-A, non-B hepatitis
21. Genomic screening for blood-borne viruses in transfusion settings
22. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
23. The risk of transfusion-transmitted infection
24. Creutzfeldt-Jakob disease and transfusion safety: Tilting at icebergs?
25. The differentiation of delayed serologic transfusion reactions and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance
26. Prenatal and perinatal immunohematology: Recommendations for serologic management of the fetus, newborn infant, and obstetric patient
27. The alloimmune thrombocytopenic syndromes
28. Passenger leukocytes, cytokines, and transfusion reactions
29. Consensus conference. Perioperative red blood cell transfusion
30. Autologous blood transfusion in the 1990's. Where is it heading?
31. Acute normovolemic hemodilution is a legitimate alternative to allogeneic blood transfusion
32. Intraoperative blood salvage: Medical controversies
33. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia and von Willebrand's disease
34. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery
35. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin
36. Current status of microbial contamination of blood components: Summary of a conference
37. Single donor platelets reduce the risk of septic transfusion reactions
38. Reducing blood donor exposure in low birth weight infants by the use of older, unwashed packed red blood cells
39. Use of leukocyte-depleted platelets and cytomegalovirus seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant
40. Transfusion-associated immunomodulation and universal white cell reduction: Are we putting the cart before the horse?
41. Current status of solvent/detergent treated frozen plasma
42. Isohemagglutinin-depleted solvent detergent plasma: A universal viral-inactivated plasma for patients of any ABO type
43. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
44. Prevention of transfusion-associated graft-versus-host disease in undiagnosed severe combined immunodeficiency syndrome
45. Clinical development of human polymerized hemoglobin as a blood substitute
46. Clinical development of perfluorocarbon-based red cell substitutes
47. Effect of hemoglobin and Perflubron-based ozygen carriers on common clinical laboratory tests
48. Infusible platelet membrane (IPM) for control of bleeding in thrombocytopenic patients